Trial · NCT01151345
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| First Intervention Period | STARTED | Tilazem 60 mg Then Angiotrofin 60 mg | 13 | |
| First Intervention Period | STARTED | Angiotrofin 60 mg Then Tilazem 60 mg | 13 | |
| First Intervention Period | Treated | Tilazem 60 mg Then Angiotrofin 60 mg | 13 | |
| First Intervention Period | Treated | Angiotrofin 60 mg Then Tilazem 60 mg | 12 | |
| First Intervention Period | COMPLETED | Tilazem 60 mg Then Angiotrofin 60 mg | 13 | |
| First Intervention Period | COMPLETED | Angiotrofin 60 mg Then Tilazem 60 mg | 12 | |
| First Intervention Period | NOT COMPLETED | Tilazem 60 mg Then Angiotrofin 60 mg | 0 | |
| First Intervention Period | NOT COMPLETED | Angiotrofin 60 mg Then Tilazem 60 mg | 1 | |
| Wash-out Period (7 Days) | STARTED | Tilazem 60 mg Then Angiotrofin 60 mg | 13 | |
| Wash-out Period (7 Days) | STARTED | Angiotrofin 60 mg Then Tilazem 60 mg | 12 | |
| Wash-out Period (7 Days) | COMPLETED | Tilazem 60 mg Then Angiotrofin 60 mg | 13 | |
| Wash-out Period (7 Days) | COMPLETED | Angiotrofin 60 mg Then Tilazem 60 mg | 12 | |
| Wash-out Period (7 Days) | NOT COMPLETED | Tilazem 60 mg Then Angiotrofin 60 mg | 0 | |
| Wash-out Period (7 Days) | NOT COMPLETED | Angiotrofin 60 mg Then Tilazem 60 mg | 0 | |
| Second Intervention Period | STARTED | Tilazem 60 mg Then Angiotrofin 60 mg | 13 | |
| Second Intervention Period | STARTED | Angiotrofin 60 mg Then Tilazem 60 mg | 12 | |
| Second Intervention Period | COMPLETED | Tilazem 60 mg Then Angiotrofin 60 mg | 13 | |
| Second Intervention Period | COMPLETED | Angiotrofin 60 mg Then Tilazem 60 mg | 12 | |
| Second Intervention Period | NOT COMPLETED | Tilazem 60 mg Then Angiotrofin 60 mg | 0 | |
| Second Intervention Period | NOT COMPLETED | Angiotrofin 60 mg Then Tilazem 60 mg | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01151345/flow